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Sequential Unfolding of Ankyrin Repeats
in Tumor Suppressor p16
[6, 7], GA binding protein GABP [8], myotrophin [9],
Swi6 [10], PYK2-associated protein  [11], and INK4
proteins p18 [12, 13] and p19 [14, 15], show the same
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University of Cambridge structural framework.
The INK4 family members, p16 [16], p15 [17], p18, andLensfield Road
Cambridge CB2 1EW p19 [18], regulate the progression of the cell cycle by
binding to CDK4/6, thereby inducing G1 phase cell cycleUnited Kindgdom
arrest. They are biochemically indistinguishable from
one another with respect to their interactions with
CDK4/6 [14, 18]. p16 consists of four ANK repeats,Summary
whereas p18 and p19 each contain five repeats, making
p16 a minimal model for analyzing the properties of theThe ANK repeat is a ubiquitous 33-residue motif that
adopts a  hairpin helix-loop-helix fold. Multiple tan- motif. Further, alterations in p16 in tumors are common,
with an occurrence of about 80% in certain tumor typesdem repeats stack in a linear manner to produce an
elongated structure that is stabilized predominantly [19–21], resulting in the classification of the protein as
a tumor suppressor protein and adding further interestby short-range interactions between residues close in
sequence. The tumor suppressor p16INK4 consists of to the study of its folding behavior.
The ANK motif is one of a number of tandem repeatfour repeats and represents the minimal ANK folding
unit. We found from value analysis that p16 unfolded motifs that have recently emerged from the wealth of
genomic data [22–26]. The fundamentally different na-sequentially. The two N-terminal ANK repeats, which
are distorted from the canonical ANK structure in all ture of these structures compared with globular do-
mains makes them a novel and highly pertinent targetINK4 proteins and which are important for functional
specificity, were mainly unstructured in the rate-lim- for protein folding studies and for testing experimental
and theoretical views that have emerged from the studyiting transition state for folding/unfolding, while the two
C-terminal repeats were fully formed. A sequential un- of globular proteins. Here, we analyze the folding path-
way of the ANK repeat p16 using  values [27, 28]. Thefolding mechanism could have implications for the cel-
lular fate of wild-type and cancer-associated mutant method monitors the formation of specific interactions
of side chains in the folding reaction and thereby allowsp16 proteins.
the structures of the rate-determining transition states
and folding intermediates to be described at the residueIntroduction
level and, even, at the atomic level. The folding mecha-
nism of a protein with a linearly repeated structure,The ankyrin repeat (ANK) is an33-residue protein motif
[1, 2] that was originally discovered in two yeast cell rather than a globular fold, has not previously been re-
solved in any detail. We found that the p16 ankyrin re-cycle regulators, Cdc10 and Swi6, and, subsequently, in
the cytoskeletal protein ankyrin [3]. It is found in proteins peats folded sequentially. The C-terminal repeats had
native structure in the rate-determining transition state,with diverse functions, including cyclin-dependent ki-
nase (CDK) inhibitors, transcriptional and develop- whereas the N-terminal repeats were largely unstruc-
tured.mental regulators, cytoskeletal proteins, and toxins in
various classes of organisms, ranging from viruses to
the human. Many ANK repeat proteins consist solely Results and Discussion
of ANK repeats, while others contain repeats that are
inserted between unrelated sequences. The number of p16 Structure and Design of Mutations
One major difference between the ANK repeat struc-tandem copies in a protein is variable, but the proteins
with fewer than four tandem repeats are uncommon. tures that have been determined to date is the extent
of  sheet structure that is formed in the loops. ThisThe crystal structure of the CDK4/CDK6 inhibitor
(INK4) p16 shows an L-shaped structural scaffold of four region forms a continuous antiparallel  sheet in p18,
whereas regular structure is present only between loopsANK repeats, with each repeat forming a helix-turn-helix
motif [4] (Figure 1). The helices of each motif pack 2 and 3, not between loops 1 and 2, in p16 and p19.
Thus, while the second and third loops are stabilizedagainst each other in an antiparallel fashion via hy-
drophobic interactions to form helical bundles in the by  turns and by intraloop hydrogen bonds involving
strictly conserved residues, the absence of this hydro-long arm of the L shape. The helix-turn-helix motifs are
connected to the neighboring repeats by long loops gen bonding network between loops 1 and 2 in p16 and
p19 means that they are held apart and have a “splayed”that are solvent exposed and fold back onto the helical
region by forming  turns. The loop axis is perpendicular arrangement [15]. The other difference is the very short
first helix of ANK II in all of the INK4 proteins in compari-to the helical axis, thus forming the base of the L shape.
Structures of other ANK repeat proteins, 53BP2 [5], IB son with the canonical ANK helices [4, 12, 14]. This
Key words: ankyrin; p16; tandem repeat; protein folding; protein*Correspondence: arf25@cam.ac.uk (A.R.F.), lsi@mrc-lmb.cam.
ac.uk (L.S.I.) engineering;  value analysis
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Table 1. Interactions Probed by Mutations of p16
Mutant Interactions Probeda
A30G Intra-ANK I (2)
A36G Intra-ANK I (2)
S43A Intraloop 1
V51A ANK II (3)-ANK I (1)/ANK II (3)
M54L ANK II (3)-ANK II (3)/ANK III (5)
A60G ANK II (4)-ANK II (3/4)
A73G Intraloop 2
A76G Intraloop 2
A86G ANK III (5)-ANK III (5/6)/ANKIV(8)
V95A ANK III (6)-ANKIII(6)/ANKIV(8)
A102G Intra-ANK III (6)
V106A Intraloop 3
A109G Intraloop 3
V115A ANK IV (7)-ANK IV (7)/(8)
V126A ANK IV (8)-ANKIII(5)/(6)
A127G ANK IV (8)-ANK IV (7)/(8)
A133G ANK IV (8)-ANKIII(6)/ANKIV(8)
A134G Intra-ANK IV (8)
a Based on the NMR solution structure of p16 [4].
peats (III and IV) and the standard, second helix of ANKII,
was fully structured. The N-terminal part, consisting of
the nonstandard regions (loop 1 and the short, first helix
Figure 1. The Structure of p16
of the second repeat), was unstructured.
This figure was created with MolScript [43]. Many of the three-state proteins studied by the protein
engineering method exhibit fractional  values in the
transition state [35–37], indicating that the interactions
region is involved in binding to the CDK [29, 30]. The are only partly formed in the transition state for folding.
C-terminal parts of the INK4 proteins appear to be more An exception is barnase, the first protein to be studied
rigid than the N-terminal parts from NMR dynamics and by this method, which shows residues in one subdomain
from proteolysis studies [31–33], and a fragment of p16 with  values of 0 and residues in the other with 
consisting of the two C-terminal ANK repeats has been values of 1, as well as a region with intermediate values
shown to be cooperatively folded [33]. [38]. The  values of the transition state for folding of
The equilibrium and kinetic folding behavior of wild- p16 were even more extremely grouped, being either
type p16 was analyzed previously [34]. Here, “nondis- close to 1 or to 0, indicating that native side chain inter-
ruptive” mutations (i.e., Ala → Gly, Val → Ala, Met →
Leu, and Ser → Ala) that delete only a small part of the
side chain were made. These mutations are ideal for 
value analysis, since a minimal number of interactions
are removed without introducing new ones, and, thus,
the overall structure and folding pathway are unper-
turbed. The interactions probed by the mutations are
summarized in Table 1. The equilibrium denaturation
curves of representative mutants are shown in Figure
2. The midpoints of unfolding, m values, and free energ-
ies of unfolding are listed in Table 2. The kinetic data
for unfolding are shown in Figure 3 and listed in Table
3. The  values for the transition state, as measured in
the unfolding direction, are listed in Table 4. A  value
of 0 means that the interaction measured is as weakly
formed in the transition state as it is in the denatured
state. A  value of 1 means that it is as energetically
well formed in the transition state as it is in the native
structure.
Structure of the Transition State Reveals
that the Protein Unfolds Sequentially
Figure 4 depicts the structure of the transition state Figure 2. Urea-Induced Equilibrium Denaturation Curves of Wild-
for folding/unfolding of p16. The extreme distribution of Type p16 and Representative Mutants
high and low  values was remarkable: the C-terminal Wild-type, open circles; A30G, crosses; A76G, filled circles; A127G,
squares.part of the protein, consisting of the standard ANK re-
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Table 2. Equilibrium Denaturation Data for p16 Wild-Type and Mutants
Mutant m (kcal M1 mol1) [U]50% (M) GDNH2O (kcal mol1) GD  N[U]50% (kcal mol1)
Wild-type 1.63  0.06 1.87  0.01 — —
ANK I
A30G 1.86  0.12 1.33  0.02 0.57  0.19 0.86  0.04
A36G 1.39  0.09 1.07  0.03 1.56  0.15 1.28  0.06
S43A 1.52  0.13 1.56  0.04 0.68  0.24 0.49  0.06
ANK II
V51A 1.53  0.04 1.30  0.01 1.04  0.12 0.90  0.02
M54L 1.32  0.17 1.30  0.06 1.33  0.26 0.91  0.10
A60G 1.52  0.18 0.65  0.07 2.06  0.20 1.95  0.12
A73G 1.53  0.07 1.22  0.02 1.19  0.14 1.04  0.04
A76G 1.65  0.28 1.56  0.07 0.48  0.46 0.50  0.11
ANK III
A86G 1.76  0.17 0.80  0.09 2.00  0.18 1.71  0.11
V95A 1.51  0.10 1.20  0.03 1.24  0.17 1.08  0.05
A102G 1.53  0.09 0.94  0.03 1.61  0.15 1.49  0.05
V106A 1.59  0.15 1.17  0.04 1.20  0.22 1.13  0.07
A109G 1.73  0.11 1.41  0.02 0.61  0.20 0.73  0.04
ANK IV
V115A 1.45  0.12 1.40  0.04 1.03  0.21 0.76  0.06
V126A 1.76  0.08 1.19  0.02 0.95  0.15 1.09  0.04
A127G 1.88  0.15 0.97  0.03 1.22  0.19 1.44  0.06
A133G 1.72  0.17 1.16  0.04 1.05  0.23 1.13  0.06
A134G 1.53  0.09 1.67  0.03 0.49  0.19 0.33  0.04
GD  N[U]50% and GD  NH2O are the changes in the free energy of unfolding upon mutation at the average midpoint of unfolding and in water,
respectively. [U]50% is the urea concentration at which the protein is 50% unfolded. A weighted average of m (m	 
 1.60  0.03) of the
wild-type p16 and nine mutants with long pretransition baselines in the denaturation curves was used to calculate GD  N[U]50%. GD  NH2O
was calculated with the individual values of m.
actions were either fully made or absent, respectively. significant curvature in the unfolding arm of the plot.
The measured and extrapolated values of the rate con-The loops appeared to be structured to the same extent
as the helices they connect. stants for folding and unfolding in water do not corre-
spond to the ratio expected from equilibrium measure-
ments. This behavior is consistent with presence of anThe Refolding Reaction of p16
Our earlier study of the folding of p16 showed that there intermediate on the pathway but does not show whether
it accumulates or is just manifested by a change in theis rollover in the refolding arm of the V-shaped plot of
the folding and unfolding kinetics [34]. There is also rate-determining step of the reaction [39]. We could not
detect the formation of an intermediate on the 80 s
to 1 ms timescale by continuous-flow studies of the
refolding reaction monitored by fluorescence.
According to microscopic reversibility, the transition
state for any unfolding step is the same as that for the
folding step under the same conditions. Accordingly, if,
as measured by unfolding kinetics, a part of the protein
has a F value of 1.0, showing that it is fully formed,
and another part has a F value of 0, showing that it is
completely unformed in that transition state, then one
can state with certainty that the latter part folds after
the former. The picture obtained for refolding is in agree-
ment with that for unfolding, as determined by the 
value analysis of the unfolding transition state. The
V-shaped plots of representative mutants are shown in
Figure 5. The mutations in p16 present a clear picture,
with those in the N-terminal part of the protein affecting
only the unfolding arm of the V-shaped plot and those
in the C-terminal part of the protein affecting only the
refolding arm. Those mutants in ANKI and the start of
ANKII, which unfold faster than wild-type (those with 
values close to 0), exhibit rates of refolding that are very
Figure 3. Urea Dependence of the Rate Constant of Unfolding of
close to that of the wild-type (see for example V51A inWild-Type p16 and Representative Mutants
Figure 5A). Thus, interactions in the N-terminal part ofWild-type, filled circles; S43A, triangles; M54L, open circles; A76G,
the protein are broken early in the unfolding and formedcrosses; A109G, squares. The fits of the data to a second-order
polynomial are shown. late in the refolding. Conversely, mutants at the end of
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Table 3. Kinetic Parameters for Unfolding of p16 Wild-Type and Mutants
Mutant kuH2O (s1) mu (M1) GI  NH2O (kcal mol1) GI  N5 M (kcal mol1)
Wild-type 0.8  0.04 0.30  0.01 — —
ANK I
A30G 1.0  0.05 0.31  0.01 0.14  0.04 0.15  0.01
A36G 5.2  0.09 0.31  0.01 1.10  0.03 1.13  0.06
S43A 2.5  0.1 0.28  0.01 0.67  0.03 0.60  0.01
ANK II
V51A 4.9  0.2 0.33  0.01 1.07  0.07 1.15  0.01
M54L 4.0  0.1 0.27  0.00 0.95  0.03 0.86  0.01
A60G 1.3  0.04 0.30  0.01 0.27  0.04 0.27  0.01
A73G 1.3  0.04 0.33  0.01 0.27  0.04 0.35  0.01
A76G 0.9  0.02 0.31  0.01 0.08  0.03 0.09  0.01
ANK III
A86G 1.1  0.13 0.28  0.03 0.16  0.03 0.08  0.06
V95A 0.6  0.01 0.32  0.01 0.14  0.03 0.09  0.01
A102G 0.9  0.04 0.30  0.01 0.03  0.04 0.02  0.02
V106A 1.0  0.03 0.31  0.01 0.15  0.03 0.17  0.01
A109G 1.1  0.04 0.30  0.01 0.19  0.04 0.19  0.01
ANK IV
V115A 0.7  0.02 0.31  0.01 0.07  0.04 0.05  0.01
V126A 0.8  0.01 0.32  0.01 0.02  0.03 0.02  0.01
A127G 0.7  0.02 0.33  0.01 0.09  0.03 0.02  0.01
A133G 0.8  0.02 0.31  0.01 0.03  0.03 0.01  0.01
A134G 0.8  0.01 0.31  0.01 0.00  0.04 0.01  0.01
kuH2O is the rate constant for unfolding in the absence of denaturant. mu is the kinetic unfolding m value. GI  NH2O and GI  N5 M are the
changes in the free energy difference between the native state, F, and the transition state, ‡, upon mutation, in the absence of denaturant
and at 5 M urea, respectively
ANKII and in ANKIII and ANKIV, which unfold at a similar the vast majority of the hydrogen bonds between CDK6
and p16/p19 involve residues that are conserved in therate to the wild-type (those with  values close to 1),
exhibit rates of refolding that are lower than that of the INK4 proteins, but not in other ANK repeat proteins. This
indicates that, in addition to the structural scaffold, therewild-type (see for example A133G in Figure 5B). Thus,
interactions in the C-terminal part of the protein are
broken late in the unfolding and formed early in the
Table 4. F Values in the Transition State of Unfolding of p16refolding.
Mutant FH2O F5 M
Structural and Functional Motifs ANK I
in the ANK Repeat A30G 0.84  0.05 0.82  0.02
The structures of the different ANK repeat motifs are A36G 0.14  0.05 0.12  0.06
S43A 0.36  0.19 0.22  0.15highly superimposable. ANK III, ANK IV, and loops 2 and
ANK II3 of p16 retained their structure in the folding transition
V51A 0.20  0.06 0.28  0.03state, and, therefore, the free energy of the transition
M54L 0.05  0.12 0.05  0.11
state relative to the native state was maintained upon A68G 0.86  0.02 0.86  0.01
mutation. Hence, we propose that the standard ANK A73G 0.74  0.04 0.67  0.02
repeats, repeats III and IV in p16, serve as a “structural A76G 0.83  0.07 0.82  0.05
ANK IIIscaffold” in the ANK repeat proteins to provide a kinet-
A86G 0.76  0.03 0.95  0.04ically stable framework.
V95A 1.13  0.03 1.08  0.01The relative lack of sequence homology in the loops
A102G 0.98  0.03 0.98  0.02
of the ANK repeat proteins suggests that these regions V106A 0.87  0.03 0.85  0.02
are important for functional specificity. Indeed, the crys- A109G 0.74  0.05 0.74  0.02
tal structures of complexes involving ANK repeat pro- ANK IV
V115A 1.09  0.05 1.04  0.01teins have demonstrated that the mechanism of binding
V126A 1.02  0.03 0.98  0.01to specific target molecules varies considerably [5, 30,
A127G 1.06  0.02 1.05  0.0440]. Other structural variations have been identified, for
A133G 1.01  0.03 0.99  0.02
example, the short first  helix of the second repeat in A134G 1.01  0.12 0.99  0.03
INK4 proteins, as described above. Also, helical inser-
F was calculated with the unfolding data as described in Experi-tions are found between ANK repeats in the proteins
mental Procedures.FH2O is the value for the transition state deter-Swi6 and IB [6, 7, 10]. Sequence variations through mined with the unfolding rate constants in the absence of denatur-
amino acid substitutions and incorporation of other se- ant.F 5 M is the value measured at 5 M urea. values were calculated
quence motifs are essential for the diversity of biological in 5 M urea for comparison with the values in 0 M urea because 5
M urea is in the middle of the urea concentration range used forfunctions. It appears that the structural scaffold of p16
the unfolding kinetics, and, therefore, a long extrapolation, leadingprovides the capacity (or thermodynamic and kinetic
to large errors in the determination of the unfolding rates and “buffering”) for the incorporation of additional structural
values at 0 M urea, is not required at 5 M urea.
elements and the resultant diversity of function. Indeed,
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Figure 4. Representation of the Transition State of the Folding of
p16 Superimposed on the Native Structure
Residues with  values close to 1 and close to 0 are shown in blue
and red, respectively.
are “functional modules” (loop 1 and the first helix of
the second repeat in p16) that are present to optimize
INK4 function.
Mutation of residues in the functional modules of p16
results in a reduction of the protein’s kinetic stability,
making it more susceptible to proteolysis and aggrega-
tion. Consistent with this, limited proteolysis studies that
show that cancer-associated mutations in the N-ter-
minal region result in its local unfolding [33]. There is a
continuous evolutionary pressure on protein sequences
that requires a balance between optimal stability and
function. In ANK repeat proteins, the structural scaffold
provides the thermodynamic and kinetic stability. In
Figure 5. V-Shaped Plots of V51A and A133Gcontrast, elements required for optimal molecular recog-
(A) V51A; (B) A133G. The mutant is shown with filled circles, andnition are located in the more flexible functional mod-
the wild-type, for comparison, is shown with open circles.ules. Thus, ANK and other tandem repeat structures
may be good starting material for protein engineering
and design of novel proteins with specified biological
activities. Finally, the sequential and directional mecha- functions, very little is known about their folding and
nism of unfolding of p16 revealed here suggests that it assembly properties. The fundamentally different nature
would be an easy substrate for degradation by the protea- of these structures compared with globular proteins
some, which has recently been shown to catalyze un- makes them a novel and important focus for protein
folding of proteins by progressively unraveling them [41]. folding studies. Here we use a protein engineering ap-
proach to obtain residue-specific detail on the folding
mechanism of a tandem-repeating structure. We showBiological Implications
that p16, an ankyrin repeat protein, unfolds in a sequen-
tial manner; first, the two N-terminal repeats and thenA class of proteins has emerged recently from the wealth
the two C-terminal repeats. Interestingly, this separationof genomic data. These consist of tandem repeats of
of folding of p16 into two parts is mirrored in its struc-short structural motifs that stack in a linear fashion to
ture-function relationship, since the region that unfoldsproduce elongated, nonglobular shapes. Their architec-
first deviates from the canonical ankyrin fold and is im-ture is distinct from the more commonly studied globular
portant for molecular recognition, while the region thatproteins. In particular, these structures lack a central
unfolds last is important for maintaining the structuralhydrophobic core and the stabilizing tertiary contacts
scaffold. It is also interesting to speculate that the se-between residues distant in sequence. Though they are
ubiquitous and appear to mediate a diverse range of quential and directional mechanism of unfolding of p16
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